Considerations in early-stage process design for cellular and gene therapy product
25 Feb 2025
C & G Bioprocessing
- How can early process designs evaluate scalability and incorporate technology to support growing demand in CGT production without compromising product integrity?
- How can early-stage CGT processes define critical quality attributes (CQAs) and implement strict quality control to ensure consistent product quality?
- How can early-stage designs for CGT ensure compliance with current and future regulatory standards, including cGMP requirements?
- How can early-stage CGT designs explore automation options and integrate technologies to support reliable, large-scale production as demand increases?
Industry Expert
